- UPSpace Home
- →
- Health Sciences
- →
- Browsing Health Sciences by Subject
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Health Sciences by Subject "Vaccine"
Now showing items 1-14 of 14
-
(Cell Press, 2022-03-15)The Janssen (Johnson & Johnson) Ad26.COV2.S non-replicating viral vector vaccine has been widely deployed for COVID-19 vaccination programs in resource-limited settings. Here we confirm that neutralizing and binding ...
-
(South African Medical Association, 2023-04)BACKGROUND : In Malawi, only 1 072 229 people out of a national target population of 13 546 324 had received at least one dose of the AstraZeneca COVID‑19 vaccine by 26 December 2021, and only 672 819 people were classified ...
-
(MDPI, 2023-09-14)CD4+ T cells have been found to play critical roles in the control of both acute and chronic Toxoplasma infection. Previous studies identified a protective role for the Toxoplasma CD4+ T celleliciting peptide AS15 ...
-
(BMC, 2022-03)BACKGROUND : Despite multiple attempts, there is still no effective HIV-1 vaccine available. The HIV-1 polymerase (pol) gene is highly conserved and encodes cytotoxic T-lymphocyte (CTL) epitopes. The aim of the study was ...
-
(South African Medical Association, 2023-01)BACKGROUND. The high HIV prevalence and incidence in South Africa makes it suitable for recruitment of participants for large-scale HIV preventive vaccine trials. However, fear of vaccine-induced seropositivity (VISP) may ...
-
(South African Dental Association, 2018-03)Dental health care personnel are at increased risk of acquiring blood-borne infections including hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Infection is acquired through ...
-
(Taylor and Francis, 2022)A fully liquid MenACWY-CRM vaccine presentation has been developed, modifying the meningococcal serogroup A (MenA) component from lyophilized to liquid. The safety and immunogenicity of the liquid presentation at the end ...
-
(Health and Medical Publishing Group, 2008-03)OBJECTIVE: The South African Thoracic Society, in conjunction with interested stakeholders, published a Guideline for Influenza Management in Adults in 1999. This year the South African Thoracic Society (SATS) identified ...
-
(Elsevier, 2017-08)BACKGROUND Efficacy of live oral rotavirus vaccines is reduced in low-income compared with high-income settings. Parenteral non-replicating rotavirus vaccines might offer benefits over oral vaccines. We assessed the ...
-
(Elsevier, 2020-07)BACKGROUND : A monovalent, parenteral, subunit rotavirus vaccine was well tolerated and immunogenic in adults in the USA and in toddlers and infants in South Africa, but elicited poor responses against heterotypic rotavirus ...
-
(Cell Press, 2022-02-15)Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOCs) exhibit escape from neutralizing antibodies, causing concern about vaccine effectiveness. However, while non-neutralizing cytotoxic ...
-
(Elsevier, 2011-11)A description of invasive Streptococcus pneumoniae isolates over a 5-year period from blood culture and cerebrospinal fluid culture follows, in Pretoria South Africa January 2005 through December 2009. Isolates were ...
-
(Elsevier, 2018-11)BACKGROUND : Rotavirus vaccination has reduced diarrhoeal morbidity and mortality globally. The monovalent rotavirus vaccine was introduced into the public immunization program in South Africa (SA) in 2009 and led to ...
-
(Elsevier, 2021-02)An efficacious COVID-19 vaccine would undoubtedly be a global public good that, in the context of a pandemic, is urgently and synchronously required by the global community. These unique features make allocation of an ...
Now showing items 1-14 of 14